David Southwell: CEO of Volastra Therapeutics

Feb. 28, 2026 Season: 8 Duration: 31:26 Episode: 88
Portrait of David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Regeneron Annual Report Cover Detail
Regeneron

Annual Report
Atrium Banner
Alexion Pharmaceuticals

Atrium Corporate Intranet
1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending